Correlation Between Mereo BioPharma and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Elevation Oncology, you can compare the effects of market volatilities on Mereo BioPharma and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Elevation Oncology.
Diversification Opportunities for Mereo BioPharma and Elevation Oncology
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mereo and Elevation is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Elevation Oncology go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Elevation Oncology
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 1.65 times less risky than Elevation Oncology. The stock trades about -0.15 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 60.00 in Elevation Oncology on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Elevation Oncology or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Elevation Oncology
Performance |
| Timeline |
| Mereo BioPharma Group |
| Elevation Oncology |
Mereo BioPharma and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Elevation Oncology
The main advantage of trading using opposite Mereo BioPharma and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| CEOs Directory Screen CEOs from public companies around the world |